MIFH
TIL icon

Migdal Insurance & Financial Holdings’s Instil Bio TIL Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46
Closed -$15K – 691
2021
Q4 		$15K Sell
46
-28
-38% -$10.8K ﹤0.01% 573
2021
Q3 		$26K Buy
+74
New +$27.6K ﹤0.01% 527

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TIL Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Instil Bio (TIL) in Q1 2022, closing a stake of 46 shares — an estimated $15K sold.

Migdal Insurance & Financial Holdings first reported a position in TIL in Q3 2021 and held it in 2 quarters. The position peaked at $26K in Q3 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Instil Bio position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 46 Instil Bio shares in Q1 2022, an estimated $15K.
  • Migdal Insurance & Financial Holdings first reported a position in Instil Bio in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Instil Bio position peaked at $26K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.